People living with schizophrenia will soon have a new and potentially groundbreaking treatment available.
With its approval, theres new hope for better managing this challenging condition.
This drug takes the first new approach to schizophrenia treatment in decades.
© Bristol Myers Squibb
In the large-scaleclinical trialsreviewed by the FDA, Cobenfy appeared to work as intended.
Compared to placebo, people on Cobenfy saw a significant improvement in their schizophrenia symptoms.
But the simple virtue of being the first in a novel drug class cant be overstated.
As monumental as this drug is, however, it may not come cheap for many people.
Its expected to hit the market by late October.
News from the future, delivered to your present.
Scientists found that childhood cat ownership is associated with developing schizophreniaa risk possibly fueled by a parasite.
